サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ウイルス検体採取市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
市場調査レポート
商品コード
1326510

ウイルス検体採取市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

Virology Specimen Collection Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented by Product Type, By Sample, By Region, and By Competition

出版日
ページ情報
英文 114 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

ウイルス検体採取市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年
出版日: 2023年08月01日
発行: TechSci Research
ページ情報: 英文 114 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ウイルス検体採取市場は、予測期間中に目覚ましい成長を遂げると予測されています。

これは、イムノアッセイ法、核酸ベースの増幅検査法、PCRベース法、質量分析法、NGS法などの高度なウイルス検体採取技術が開発され、世界中のさまざまなウイルス感染に対して正確で迅速な結果が得られるようになったためと考えられます。製薬・バイオ医薬品業界における研究開発の高まりとともに。また、新薬開発のためのバイオ医薬品における高分子への注目の高まりは、予測期間における市場の成長をさらに後押しします。同様に、検出技術、投薬、ワクチンなど、抗ウイルス療法における進歩の拡大も、予測期間中の市場成長を後押しすると予想されます。

ラボ検査の増加

ウイルスを簡単に検出するための迅速検査が増加していることは、長年にわたって市場の成長を促進すると予想されます。検査結果の正確性は、正確な診断や治療方針を決定する上で重要です。そのため、迅速診断検査は、処方箋の改善や入院期間の短縮など、迅速かつ迅速な結果を得るために使用され、予測期間中の市場の成長をさらに促進します。世界保健機関（WHO）が2021年11月に発表したデータによると、世界中で毎日100万人以上の性感染症（S.T.I.）が発症しています。これらの検査は、患者から血液や尿などのサンプルを採取し、特定の病状を診断し、最も可能性の高い治療方針を決定することで、正確な結果を得るために必要なものです。

ウイルス性疾患の有病率の上昇と新しい病原体の出現

ジカウイルスやバベシア病の発生など、ウイルス性疾患の流行の増加は、予測期間中にウイルス検体採取市場の需要を高めると思われます。また、革新的なウイルス検体採取技術、消耗品、器具に対する需要の高まりは、長年にわたる市場の成長をさらに促進すると思われます。アフリカ地域でのマラリアの流行や、蚊を媒介としたジカ熱感染の可能性など、他の国々は新しい病気や新興の病気をチェックする取り組みを始めており、その結果、この地域ではジカウイルスのスクリーニングが義務付けられています。世界保健機関（WHO）によると、2021年11月、2020年末時点で推定3,770万人が HIVに罹患しています。このうち、3分の2を超える2,540万人がWHOアフリカ地域に居住しています。2020年には、約68万人がHIVが原因で死亡し、150万人（100万～200万人）がHIVに感染します。また、世界保健機関（WHO）が2021年7月に発表したデータによると、2020年の梅毒の新規感染者は全世界で700万人と推定されています。このことは、ウイルス検体採取市場の需要を長年にわたってさらに押し上げると予想されます。

利用可能なカスタマイズ

TechSci Researchでは、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供しています。レポートでは以下のカスタマイズが可能です、

企業情報

  • 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のウイルス検体採取市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別（ウイルス輸送媒体、検体採取チューブ、スワブ、採血キット）
    • 検体別（血液検体、子宮頸部検体、鼻腔検体、鼻咽頭検体、咽頭検体、口腔検体、その他検体）
    • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
    • 企業別（2022）
  • 市場マップ
    • 製品タイプ別
    • サンプル別
    • 地域別

第6章 北米のウイルス検体採取市場の展望

  • 市場規模・予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 検体別
    • 国別
  • 北米,国別分析
    • 米国
    • カナダ
    • メキシコ

第7章 欧州のウイルス検体採取市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 検体別
    • 国別
  • 欧州、国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のウイルス検体採取市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 検体別
    • 国別
  • アジア太平洋地域国別分析
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア

第9章 南米のウイルス検体採取市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 検体別
    • 国別
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのウイルス検体採取市場の展望

  • 市場規模と予測
    • 金額別
  • 市場シェアと予測
    • 製品タイプ別
    • 検体別
    • 国別
  • MEA：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 最近の展開
  • 合併・買収
  • 製品発表

第13章 世界のウイルス検体採取市場、SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Becton, Dickinson and Company.
    • Quidel Corporation.
    • Thermo Fisher Scintific Inc.
    • Trinity Biotech PLC.
    • Titan Biotech Ltd.
    • Diasorin SA.
    • Vircell S.L.
    • Copan Italia S.P.A
    • Puritan Medical Products Co.
    • Hardy Diagnostics Inc.

第16章 戦略的提言

目次
Product Code: 15096

Virology Specimen Collection market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the development of advanced viral specimen collection technologies such as immunoassay, nucleic acid-based amplification testing methods or PCR-based methods, mass spectrometry, and NGS methods for accurate, quick results for different viral infections across the globe. Along with the rising research and development in the pharmaceutical and biopharmaceutical industry. Also, the growing focuses on the large molecule in biopharmaceuticals for developing novel drugs will further boost the growth of the market in the forecasted period. Similarly, growing advances in anti-viral therapy in terms of detection techniques, medication, and vaccines are expected to boost the growth of the market during the forecast period.

The increasing number of laboratory tests

The increasing number of rapid tests for easy detection of viruses is expected to drive the growth of the market over the years. The accuracy of test results is important in making accurate diagnostic and therapeutic decisions. So rapid diagnostic tests are used for rapid and faster results with improving prescribed and reduced time for hospitalization which will further drive the growth of the market during the forecast period. According to the data published by the World Health Organization (WHO), in November 2021, over 1 million sexually transmitted infections (S.T.I.s) are acquired every day across the world. These tests are necessary for accurate results by the collection of blood, urine, or other samples from patients to diagnose their specific medical condition and determine the most likely course of treatment.

Also, some other important clinical laboratory tests are used for virus detection, such as clinical chemistry, hematology, D.N.A. testing, reproductive biology tests, complete blood count (C.B.C.), comprehensive metabolic panel, basic metabolic panel, liver panel, lipid panel, HbA1c, HGB/HCT, urinalysis, and thyroid-stimulating hormone. Hence, the Global Virology Specimen Collection Market will grow with different laboratory tests available, which are increasingly accepted by clinicians to navigate through highly contagious infections that include Ebola, Middle East respiratory syndrome coronavirus (MERS-CoV), and hantavirus. This is expected to enhance the usage rate of viral specimen collection products for rapid diagnostic tests across the globe in the forecast period.

Rising prevalence of viral diseases and the emergence of newer pathogens

The growing prevalence of viral diseases, such as outbreaks of the Zika virus and Babesia, will enhance the demand for the virology specimen collection market during the forecast period. Also, the growing demand for innovative virology specimen collection technology, consumables, and instruments will further drive the growth of the market over the years. Other countries have started initiatives to check for new and emerging diseases, such as the prevalence of malaria in African regions and the possibility of mosquito-borne transfer of Zika, resulting in mandates for Zika virus screening in the region. According to the World Health Organization (WHO), in November 2021, an estimated 37.7 million people were affected by H.I.V. at the end of 2020. Out of these, over two-thirds, (25.4 million) of the population were residing in the WHO African Region. In 2020, approximately 680,000 people died from HIV-related causes and 1.5 million (1.0-2.0 million) people acquired the disease. In addition, as per the data published by World Health Organization (WHO) in July 2021, there were an estimated 7 million new syphilis infections in 2020 across the globe. This, in turn, is expected to further boost the demand for the Virology Specimen Collection Market over the years.

Market Segmentation

Global Virology Specimen Collection Market can be segmented by product type, sample, and by region. Based on the product type, the market can be segmented into Viral Transport Media, Specimen Collection Tubes, Swabs, and Blood Collection Kits. Based on the sample, the market can be segmented into Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, and Other Samples. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global Virology Specimen Collection market on account of the growing well-developed laboratories in the country.

Recent Development

  • In November 2020, Mybiopassport (Switzerland) launched its e-Commerce platform for online ordering of the "COVID-19 & Immunity Profile" test, an at-home blood collection test. The test helps determine if the individual has been previously infected by COVID-19 through the development of specific antibodies.
  • In April 2020, the University of Rochester Medical Center Rochester (U.S.) developed a finger-stick test for detecting more than 50 strains of the flu from just a few blood drops.
  • In February 2020, Thermo Fisher Scientific (U.S.) announced its collaboration with NanoPin Technologies, Inc. for developing highly sensitive liquid chromatography-mass spectrometry (LC-MS) based workflows to advance the detection technology for blood-based infectious diseases.

Market Players

Becton, Dickinson and Company, Quidel Corporation, Thermo Fisher Scintific Inc., Trinity Biotech P.L.C., Titan Biotech Ltd., Diasorin SA., Vircell S.L., Copan Italia S.P.A., Puritan Medical Products Co., Hardy Diagnostics Inc are some of the leading players operating in the Global Virology Specimen Collection Market.

Report Scope

In this report, global Virology Specimen Collection market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below,

Virology Specimen Collection Market, By Product Type:

  • Viral Transport Media
  • Specimen Collection Tubes
  • Swabs
  • Blood Collection Kits

Virology Specimen Collection Market, By Sample:

  • Blood Samples
  • Cervical Samples
  • Nasal Samples
  • Nasopharyngeal Samples
  • Throat Samples
  • Oral Samples
  • Other Samples

Virology Specimen Collection Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • U.A.E.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Virology Specimen Collection Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report,

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virology Specimen Collection Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 5.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.4. By Company (2022)
  • 5.3. Market Map
    • 5.3.1 By Product Type
    • 5.3.2 By Sample
    • 5.3.3 By Region

6. North America Virology Specimen Collection Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 6.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 6.2.3. By Country
  • 6.3. North America, Country Analysis
    • 6.3.1. United States Virology Specimen Collection Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Sample
    • 6.3.2. Canada Virology Specimen Collection Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Sample
    • 6.3.3. Mexico Virology Specimen Collection Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Sample

7. Europe Virology Specimen Collection Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 7.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 7.2.3. By Country
  • 7.3. Europe, Country Analysis
    • 7.3.1. France Virology Specimen Collection Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Sample
    • 7.3.2. Germany Virology Specimen Collection Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Sample
    • 7.3.3. United Kingdom Virology Specimen Collection Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Sample
    • 7.3.4. Italy Virology Specimen Collection Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Sample
    • 7.3.5. Spain Virology Specimen Collection Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Sample

8. Asia-Pacific Virology Specimen Collection Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 8.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Virology Specimen Collection Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Sample
    • 8.3.2. India Virology Specimen Collection Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Sample
    • 8.3.3. Japan Virology Specimen Collection Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Sample
    • 8.3.4. South Korea Virology Specimen Collection Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Sample
    • 8.3.5. Australia Virology Specimen Collection Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Sample

9. South America Virology Specimen Collection Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 9.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Virology Specimen Collection Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Sample
    • 9.3.2. Argentina Virology Specimen Collection Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Sample
    • 9.3.3. Colombia Virology Specimen Collection Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Sample

10. Middle East and Africa Virology Specimen Collection Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type (Viral Transport Media, Specimen Collection Tubes, Swabs, Blood Collection Kits)
    • 10.2.2. By Sample (Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Throat Samples, Oral Samples, Other Samples)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Virology Specimen Collection Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Sample
    • 10.3.2. Saudi Arabia Virology Specimen Collection Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Sample
    • 10.3.3. UAE Virology Specimen Collection Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Sample

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Virology Specimen Collection Market, SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Product Offerings
  • 15.3. Recent Developments
  • 15.4. Financials (As Reported)
  • 15.5. Key Personnel
  • 15.6. SWOT Analysis
    • 15.6.1 Becton, Dickinson and Company.
    • 15.6.2 Quidel Corporation.
    • 15.6.3 Thermo Fisher Scintific Inc.
    • 15.6.4 Trinity Biotech PLC.
    • 15.6.5 Titan Biotech Ltd.
    • 15.6.6 Diasorin SA.
    • 15.6.7 Vircell S.L.
    • 15.6.8 Copan Italia S.P.A
    • 15.6.9 Puritan Medical Products Co.
    • 15.6.10 Hardy Diagnostics Inc.

16. Strategic Recommendations